Is vaccine confidence an unexpected victim of the COVID-19 pandemic?
•Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence.•Vaccine confidence has significantly declined since the onset of the COVID-19 pandemic.•All demographic groups showed a reduction in vaccine confidence post-pandemic.•Post-pandemic, middle-age participants...
Saved in:
Published in | Vaccine Vol. 40; no. 50; pp. 7262 - 7269 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
28.11.2022
Elsevier Limited The Authors. Published by Elsevier Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence.•Vaccine confidence has significantly declined since the onset of the COVID-19 pandemic.•All demographic groups showed a reduction in vaccine confidence post-pandemic.•Post-pandemic, middle-age participants were no longer the most vaccine-hesitant group.
Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants.
Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones.
This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups. |
---|---|
AbstractList | Highlights•Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence. •Vaccine confidence has significantly declined since the onset of the COVID-19 pandemic. •All demographic groups showed a reduction in vaccine confidence post-pandemic. •Post-pandemic, middle-age participants were no longer the most vaccine-hesitant group. Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups. Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups.Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups. •Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence.•Vaccine confidence has significantly declined since the onset of the COVID-19 pandemic.•All demographic groups showed a reduction in vaccine confidence post-pandemic.•Post-pandemic, middle-age participants were no longer the most vaccine-hesitant group. Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups. Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical companies and national health services, COVID-19 vaccination campaigns were successfully rolled out less than a year after the start of the pandemic. While the unprecedented speed of development and approval of COVID-19 vaccines has been applauded as a public health success story, it also spurred considerable controversy and hesitancy even amongst individuals that did not previously hold anti-vaccination stances. This study aimed to compare pre- and post-pandemic vaccine confidence trends in different demographic groups by analysing the outcomes of two online surveys run respectively in November 2019 and January 2022 involving a total of 1009 participants. Non-parametric tests highlighted a statistically significant decline in vaccine confidence in the 2022 cohort compared to the 2019 cohort, with median Vaccine Confidence Score dropping from 22 to 20 and 23.8% of participants reporting that their confidence in vaccines had declined since the onset of the pandemic. While the majority of internal trends were comparable between the two surveys with regards to gender, graduate status and religious belief, vaccine confidence patterns showed considerable alterations with regards to age and ethnicity. Middle-aged participants were considerably more hesitant than younger groups in the 2019 cohort, however this was not the case in the 2022 survey. In both surveys White participants showed significantly higher vaccine confidence than those from Black backgrounds; in the 2022 cohort, unlike the pre-pandemic group, Asian participants showed significantly lower confidence than White ones. This study suggests that paradoxically, despite the success of COVID-19 vaccination campaigns, vaccine confidence has significantly declined since the onset of the pandemic; the comparison of a pre- and post-pandemic cohort sheds light on the differential effect that the pandemic had on vaccine confidence in different demographic groups. |
Author | Tranter, Amy Siani, Alessandro |
Author_xml | – sequence: 1 givenname: Alessandro orcidid: 0000-0002-0652-2489 surname: Siani fullname: Siani, Alessandro email: alessandro.siani@port.ac.uk – sequence: 2 givenname: Amy surname: Tranter fullname: Tranter, Amy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36333226$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkt1rE0EUxQep2LT6JygLvviy6XzvLmKLpFoDhT74gW_D7J27duJmJu5sgv3v3SUxaEDi08Cd3z0czrln5CTEgIQ8Z3TKKNMXi-nGAviAU045H2ZTqtkjMmFlIXKuWHlCJpRrmUtGv56Ss5QWlFIlWPWEnAothOBcT8j1PGU7oQxiaLzDAJjZkK0D_lwh9OiyjYfeL7PYZP09ZrO7L_PrnFXZygaHSw9XT8njxrYJn-3ec_L5_btPsw_57d3NfPb2Ngeliz5XTNV12ZSDDXB143QhQVbSWaxsIXQNTaEAlKVN1Ths6lKA0JzWsnRMo0RxTi63uqt1vUQHGPrOtmbV-aXtHky03vz9E_y9-RY3ptKslFINAq92Al38scbUm6VPgG1rA8Z1MoJLTiWTpT6K8kJwJQWjI_ryAF3EdReGJEaqkLKkqhyoF3-a37v-3cUAqC0AXUypw2aPMGrGzs3C7KoyY-fjeOh82Ht9sAe-t72PYwa-Pbp9td3GobiNx84k8OMNON8N7RsX_VGFywMFaH3wYNvv-IBpnwUziRtqPo5XOR4l55QJUYzJvPm3wH8Y-AVCB_Nl |
CitedBy_id | crossref_primary_10_1186_s12889_024_18489_8 crossref_primary_10_1080_22423982_2023_2295042 crossref_primary_10_3390_covid5040045 crossref_primary_10_1016_j_vaccine_2024_126236 crossref_primary_10_1016_j_vaccine_2023_12_080 crossref_primary_10_2196_56559 crossref_primary_10_3389_fpubh_2023_1148029 crossref_primary_10_1186_s12913_023_10141_2 crossref_primary_10_1007_s44202_024_00288_2 crossref_primary_10_3390_vaccines12050458 crossref_primary_10_1038_s41404_022_1824_6 crossref_primary_10_1080_21645515_2023_2225388 crossref_primary_10_1164_rccm_202410_1883VP crossref_primary_10_1016_j_vaccine_2024_06_037 crossref_primary_10_1080_21645515_2025_2457198 crossref_primary_10_1111_trf_18051 crossref_primary_10_1080_21645515_2023_2265640 crossref_primary_10_1002_ase_2417 crossref_primary_10_7759_cureus_56943 crossref_primary_10_1093_jtm_taad056 crossref_primary_10_1097_IPC_0000000000001352 crossref_primary_10_1007_s10461_025_04622_0 crossref_primary_10_1016_j_vaccine_2023_03_030 crossref_primary_10_51819_jaltc_2023_1374608 crossref_primary_10_1080_21645515_2023_2237374 crossref_primary_10_1515_ohe_2023_0016 crossref_primary_10_37016_mr_2020_148 crossref_primary_10_1111_jrh_12839 crossref_primary_10_12968_bjhc_2023_0105 crossref_primary_10_1016_j_vaccine_2024_06_047 crossref_primary_10_1186_s12889_024_20953_4 |
Cites_doi | 10.1016/j.vaccine.2015.04.036 10.3389/fpubh.2022.878159 10.1016/j.vaccine.2020.04.068 10.7591/9781501735639 10.1016/j.jiph.2022.06.007 10.1111/1467-9566.13474 10.1016/j.vaccine.2014.09.039 10.1038/d41586-020-03626-1 10.1016/j.ypmed.2019.02.011 10.4161/hv.26224 10.1016/S0140-6736(21)00306-8 10.15585/mmwr.mm7105a3 10.1001/jama.2020.15725 10.3389/fpubh.2022.824560 10.1016/j.eclinm.2020.100387 10.1016/S0140-6736(21)02178-4 10.3389/fpubh.2021.752323 10.1371/journal.pone.0258462 10.1007/s11845-021-02640-0 10.1016/j.puhe.2021.02.025 10.1016/B978-1-4160-3611-1.50005-2 10.1371/journal.pone.0250123 10.1016/j.immuni.2021.07.017 10.1016/j.vaccine.2017.12.043 |
ContentType | Journal Article |
Copyright | 2022 The Authors The Authors Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. 2022. The Authors 2022 The Authors. Published by Elsevier Ltd. 2022 |
Copyright_xml | – notice: 2022 The Authors – notice: The Authors – notice: Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. – notice: 2022. The Authors – notice: 2022 The Authors. Published by Elsevier Ltd. 2022 |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 7S9 L.6 5PM |
DOI | 10.1016/j.vaccine.2022.10.061 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Consumer Health Database Health & Medical Collection (Alumni) Healthcare Administration Database Proquest Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Research Library Prep AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology Public Health |
EISSN | 1873-2518 |
EndPage | 7269 |
ExternalDocumentID | PMC9618445 36333226 10_1016_j_vaccine_2022_10_061 S0264410X22013378 1_s2_0_S0264410X22013378 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACVFH ADBBV ADCNI ADEZE ADFRT AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEUYN AEVXI AEXOQ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGGSO AGUBO AGYEJ AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EFKBS EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN FYUFA G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO Q38 ROL RPZ SAB SCC SDF SDG SDP SES SNL SPCBC SSH SSI SSZ T5K UKHRP UV1 WH7 WOW Z5R ~G- .GJ 29Q 3V. AACTN AAQXK ABWVN ABXDB ACRPL ADMUD ADNMO ADVLN AFCTW AFJKZ AFKWA AGHFR AHHHB AJOXV ALIPV AMFUW ASPBG AVWKF AZFZN EJD FEDTE FGOYB G-2 HEJ HLV HMG HMK HMO HVGLF HX~ HZ~ R2- RIG SAE SEW SIN SVS WUQ XPP ZGI ZXP 6I. AAFTH AAIAV ABLVK ABYKQ AESVU EFLBG LCYCR QYZTP AAYXX ACMHX ADSLC AGQPQ AGRNS AGWPP CITATION CGR CUY CVF ECM EIF NPM 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c567t-515bb8f8005cdbfd674c494dae9a736bcf75cc5a0f9fdefb83c3620b48d16e4e3 |
IEDL.DBID | 7X7 |
ISSN | 0264-410X 1873-2518 |
IngestDate | Thu Aug 21 18:38:35 EDT 2025 Fri Aug 22 20:26:28 EDT 2025 Fri Jul 11 00:36:00 EDT 2025 Wed Aug 13 07:22:42 EDT 2025 Wed Feb 19 02:26:10 EST 2025 Tue Jul 01 01:07:10 EDT 2025 Thu Apr 24 22:58:28 EDT 2025 Fri Feb 23 02:38:54 EST 2024 Tue Feb 25 20:07:26 EST 2025 Tue Aug 26 16:34:38 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 50 |
Keywords | COVID-19 Demographics Survey Vaccine hesitancy Vaccine confidence |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c567t-515bb8f8005cdbfd674c494dae9a736bcf75cc5a0f9fdefb83c3620b48d16e4e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-0652-2489 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0264410X22013378 |
PMID | 36333226 |
PQID | 2737448058 |
PQPubID | 105530 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9618445 proquest_miscellaneous_3242041486 proquest_miscellaneous_2732543106 proquest_journals_2737448058 pubmed_primary_36333226 crossref_primary_10_1016_j_vaccine_2022_10_061 crossref_citationtrail_10_1016_j_vaccine_2022_10_061 elsevier_sciencedirect_doi_10_1016_j_vaccine_2022_10_061 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X22013378 elsevier_clinicalkey_doi_10_1016_j_vaccine_2022_10_061 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-11-28 |
PublicationDateYYYYMMDD | 2022-11-28 |
PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: Kidlington |
PublicationTitle | Vaccine |
PublicationTitleAlternate | Vaccine |
PublicationYear | 2022 |
Publisher | Elsevier Ltd Elsevier Limited The Authors. Published by Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited – name: The Authors. Published by Elsevier Ltd |
References | Ball (b0075) 2021; 589 Lee, Sibley (b0170) 2020; 23 World Health Organization. Report of the SAGE Working Group on Vaccine Hesitancy; 2014. Patel, Berenson (b0175) 2013; 9 Bok K, Sitar S, Graham BS, Mascola JR. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. 8 ed. United States: Elsevier Science B.V., Amsterdam; 2021. p. 1636–51. Woolf, McManus, Martin, Nellums, Guyatt, Melbourne (b0185) 2021; 9 MacDonald (b0055) 2015; 33 Fadi, Mohamad-Hani, Khalid, Shuliweeh, Ali, Abdulkarim (b0120) 2022; 15 Siani, Driscoll, Hurst, Coker, Grantham, Bunet (b0105) 2021 Shah, Marks, Hahn (b0090) 2020; 324 Razai, Osama, McKechnie, Majeed (b0190) 2021; 372 World Health Organization. Ten threats to global health in 2019; 2019. Wouters, Shadlen, Salcher-Konrad, Pollard, Larson, Teerawattananon (b0095) 2021; 397 Troiano, Nardi (b0080) 2021; 194 Dube E, Gagnon D, Nickels E, Jeram S, Schuster M. Mapping vaccine hesitancy-Country-specific characteristics of a global phenomenon. Great Britain: Elsevier Science B.V., Amsterdam.; 2014. p. 6649. Siani (b0050) 2019; 121 McNaghten AD, Brewer NT, Mei-Chuan H, Peng-Jun L, Daskalakis D, Abad N, et al. COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity -- United States, August 29-October 30, 2021. MMWR: Morbidity & Mortality Weekly Report. 2022;71:171–6. Gerretsen, Kim, Caravaggio, Quilty, Sanches, Wells (b0065) 2021; 16 Morales, Beltran, Morales (b0155) 2022 Falcaro, Castañon, Ndlela, Checchi, Soldan, Lopez-Bernal (b0020) 2021; 398 Wakefield, Murch, Anthony, Linnell, Casson, Malik (b0025) 1998 Siani A. Vaccine hesitancy and refusal: history, causes, mitigation strategies. In: Rezaei N, editor. Integrated Science of Global Epidemics: Springer; 2022. ISBN: 978-3-031-17777-4, Series E-ISSN: 2662-947X. Shapiro GK, Amsel R, Knauper B, Perez S, Rosberger Z, Tatar O, et al. The vaccine hesitancy scale: Psychometric properties and validation. Vaccine 2018;36:660-7-7. doi: 10.1016/j.vaccine.2017.12.043. Our World In Data. Coronavirus (COVID-19) Vaccinations; 2022. Fridman, Gershon, Gneezy (b0110) 2021; 16 Kibongani Volet, Scavone, Catalán-Matamoros, Capuano (b0160) 2022; 10 Hausman BL. Anti/Vax: reframing the vaccination controversy: Ilr Press; 2019. Temsah, Aljamaan, Alenezi, Alhasan, Alrabiaah, Assiri (b0115) 2022; 10 Spetz, Lundberg, Nwaru, Li, Santosa, Leach (b0125) 2022; 15 Zintel, Flock, Arbogast, Forster, von Wagner, Sieverding (b0135) 2022 Temsah M-H, Alhuzaimi AN, Aljamaan F, Bahkali F, Al-Eyadhy A, Alrabiaah A, et al. Parental attitudes and hesitancy about COVID-19 versus routine childhood vaccinations: a national survey. Front Public Health 2021:1513. Siani, Carter, Moulton (b0180) 2022; 63 Sreevatsava, Burman, Wahdan, Safdar, O'Leary, Amjad (b0040) 2020; 38 World Health Organization. Vaccines and immunization; 2022. Arvanitis, Opsasnick, O'Conor, Curtis, Vuyyuru, Yoshino Benavente (b0130) 2021; 24 Plotkin SL, Plotkin SA. A short history of vaccination. Vaccines 2004;5:1–16. Barry, Temsah, Aljamaan, Saddik, Al-Eyadhy, Alenezi (b0140) 2021 Nazlı, Yığman, Sevindik, Deniz (b0085) 2022; 191 Morales (10.1016/j.vaccine.2022.10.061_b0155) 2022 Falcaro (10.1016/j.vaccine.2022.10.061_b0020) 2021; 398 Arvanitis (10.1016/j.vaccine.2022.10.061_b0130) 2021; 24 Siani (10.1016/j.vaccine.2022.10.061_b0180) 2022; 63 Shah (10.1016/j.vaccine.2022.10.061_b0090) 2020; 324 Troiano (10.1016/j.vaccine.2022.10.061_b0080) 2021; 194 MacDonald (10.1016/j.vaccine.2022.10.061_b0055) 2015; 33 Patel (10.1016/j.vaccine.2022.10.061_b0175) 2013; 9 10.1016/j.vaccine.2022.10.061_b0060 Siani (10.1016/j.vaccine.2022.10.061_b0105) 2021 Ball (10.1016/j.vaccine.2022.10.061_b0075) 2021; 589 Fridman (10.1016/j.vaccine.2022.10.061_b0110) 2021; 16 10.1016/j.vaccine.2022.10.061_b0165 10.1016/j.vaccine.2022.10.061_b0045 10.1016/j.vaccine.2022.10.061_b0100 Sreevatsava (10.1016/j.vaccine.2022.10.061_b0040) 2020; 38 Wouters (10.1016/j.vaccine.2022.10.061_b0095) 2021; 397 Kibongani Volet (10.1016/j.vaccine.2022.10.061_b0160) 2022; 10 10.1016/j.vaccine.2022.10.061_b0005 10.1016/j.vaccine.2022.10.061_b0145 Fadi (10.1016/j.vaccine.2022.10.061_b0120) 2022; 15 Nazlı (10.1016/j.vaccine.2022.10.061_b0085) 2022; 191 Razai (10.1016/j.vaccine.2022.10.061_b0190) 2021; 372 Wakefield (10.1016/j.vaccine.2022.10.061_b0025) 1998 Gerretsen (10.1016/j.vaccine.2022.10.061_b0065) 2021; 16 Temsah (10.1016/j.vaccine.2022.10.061_b0115) 2022; 10 Zintel (10.1016/j.vaccine.2022.10.061_b0135) 2022 Woolf (10.1016/j.vaccine.2022.10.061_b0185) 2021; 9 Spetz (10.1016/j.vaccine.2022.10.061_b0125) 2022; 15 10.1016/j.vaccine.2022.10.061_b0070 Barry (10.1016/j.vaccine.2022.10.061_b0140) 2021 Lee (10.1016/j.vaccine.2022.10.061_b0170) 2020; 23 Siani (10.1016/j.vaccine.2022.10.061_b0050) 2019; 121 10.1016/j.vaccine.2022.10.061_b0150 10.1016/j.vaccine.2022.10.061_b0030 10.1016/j.vaccine.2022.10.061_b0010 10.1016/j.vaccine.2022.10.061_b0015 10.1016/j.vaccine.2022.10.061_b0035 |
References_xml | – reference: Bok K, Sitar S, Graham BS, Mascola JR. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. 8 ed. United States: Elsevier Science B.V., Amsterdam; 2021. p. 1636–51. – year: 1998 ident: b0025 article-title: RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children – reference: Our World In Data. Coronavirus (COVID-19) Vaccinations; 2022. – volume: 63 year: 2022 ident: b0180 article-title: Political views and science literacy as indicators of vaccine confidence and COVID-19 concern publication-title: J Prevent Med Hygiene – volume: 15 start-page: 773 year: 2022 end-page: 780 ident: b0120 article-title: SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes publication-title: J Infect Public Health – volume: 9 year: 2021 ident: b0185 article-title: Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study publication-title: Lancet Reg Health Europe – volume: 589 start-page: 16 year: 2021 end-page: 18 ident: b0075 article-title: The lightning-fast quest for COVID vaccines - and what it means for other diseases publication-title: Nature – reference: Shapiro GK, Amsel R, Knauper B, Perez S, Rosberger Z, Tatar O, et al. The vaccine hesitancy scale: Psychometric properties and validation. Vaccine 2018;36:660-7-7. doi: 10.1016/j.vaccine.2017.12.043. – volume: 324 start-page: 931 year: 2020 end-page: 932 ident: b0090 article-title: Unwavering Regulatory Safeguards for COVID-19 Vaccines publication-title: JAMA – reference: World Health Organization. Ten threats to global health in 2019; 2019. – volume: 121 start-page: 99 year: 2019 end-page: 104 ident: b0050 article-title: Measles outbreaks in Italy: A paradigm of the re-emergence of vaccine-preventable diseases in developed countries publication-title: Prev Med – reference: Hausman BL. Anti/Vax: reframing the vaccination controversy: Ilr Press; 2019. – reference: Siani A. Vaccine hesitancy and refusal: history, causes, mitigation strategies. In: Rezaei N, editor. Integrated Science of Global Epidemics: Springer; 2022. ISBN: 978-3-031-17777-4, Series E-ISSN: 2662-947X. – volume: 191 start-page: 71 year: 2022 end-page: 80 ident: b0085 article-title: Psychological factors affecting COVID-19 vaccine hesitancy publication-title: Ir J Med Sci – volume: 10 year: 2022 ident: b0115 article-title: SARS-COV-2 omicron variant: exploring healthcare workers' awareness and perception of vaccine effectiveness: a national survey during the first week of WHO variant alert publication-title: Front Public Health – volume: 23 year: 2020 ident: b0170 article-title: Attitudes toward vaccinations are becoming more polarized in New Zealand: Findings from a longitudinal survey publication-title: EClinicalMedicine – reference: World Health Organization. Vaccines and immunization; 2022. – volume: 16 start-page: e0258462 year: 2021 ident: b0065 article-title: Individual determinants of COVID-19 vaccine hesitancy publication-title: PLoS ONE – start-page: 5762 year: 2021 end-page: 5768 ident: b0140 article-title: COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout – year: 2022 ident: b0155 article-title: Gender, socioeconomic status, and COVID-19 vaccine hesitancy in the US: An intersectionality approach publication-title: Sociol Health Illn – volume: 24 year: 2021 ident: b0130 article-title: Factors associated with COVID-19 vaccine trust and hesitancy among adults with chronic conditions publication-title: Prevent Med Rep – reference: McNaghten AD, Brewer NT, Mei-Chuan H, Peng-Jun L, Daskalakis D, Abad N, et al. COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity -- United States, August 29-October 30, 2021. MMWR: Morbidity & Mortality Weekly Report. 2022;71:171–6. – volume: 10 year: 2022 ident: b0160 article-title: Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust publication-title: Front Public Health – start-page: 1 year: 2022 end-page: 25 ident: b0135 article-title: Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis publication-title: Zeitschrift fur Gesundheitswissenschaften = J Public Health – volume: 372 year: 2021 ident: b0190 article-title: Covid-19 vaccine hesitancy among ethnic minority groups publication-title: BMJ (Clinical Research ed) – volume: 15 year: 2022 ident: b0125 article-title: The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden publication-title: Lancet Reg Health Europe – volume: 9 start-page: 2649 year: 2013 end-page: 2653 ident: b0175 article-title: Sources of HPV vaccine hesitancy in parents publication-title: Human Vaccines Immunother – volume: 38 start-page: 4399 year: 2020 end-page: 4404 ident: b0040 article-title: Routine immunization coverage in Pakistan: a survey of children under 1 year of age in community-based vaccination areas publication-title: Vaccine – volume: 194 start-page: 245 year: 2021 end-page: 251 ident: b0080 article-title: Vaccine hesitancy in the era of COVID-19 publication-title: Public Health – reference: Temsah M-H, Alhuzaimi AN, Aljamaan F, Bahkali F, Al-Eyadhy A, Alrabiaah A, et al. Parental attitudes and hesitancy about COVID-19 versus routine childhood vaccinations: a national survey. Front Public Health 2021:1513. – reference: Plotkin SL, Plotkin SA. A short history of vaccination. Vaccines 2004;5:1–16. – volume: 398 start-page: 2084 year: 2021 end-page: 2092 ident: b0020 article-title: The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study publication-title: Lancet – start-page: 1 year: 2021 end-page: 9 ident: b0105 article-title: Investigating the determinants of vaccine hesitancy within undergraduate students' social sphere publication-title: J Public Health – reference: Dube E, Gagnon D, Nickels E, Jeram S, Schuster M. Mapping vaccine hesitancy-Country-specific characteristics of a global phenomenon. Great Britain: Elsevier Science B.V., Amsterdam.; 2014. p. 6649. – volume: 33 start-page: 4161 year: 2015 end-page: 4164 ident: b0055 article-title: Vaccine hesitancy: Definition, scope and determinants publication-title: Vaccine – volume: 397 start-page: 1023 year: 2021 end-page: 1034 ident: b0095 article-title: Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment publication-title: Lancet – reference: World Health Organization. Report of the SAGE Working Group on Vaccine Hesitancy; 2014. – volume: 16 year: 2021 ident: b0110 article-title: COVID-19 and vaccine hesitancy: A longitudinal study publication-title: PLoS ONE – volume: 33 start-page: 4161 year: 2015 ident: 10.1016/j.vaccine.2022.10.061_b0055 article-title: Vaccine hesitancy: Definition, scope and determinants publication-title: Vaccine doi: 10.1016/j.vaccine.2015.04.036 – year: 1998 ident: 10.1016/j.vaccine.2022.10.061_b0025 – volume: 10 year: 2022 ident: 10.1016/j.vaccine.2022.10.061_b0115 article-title: SARS-COV-2 omicron variant: exploring healthcare workers' awareness and perception of vaccine effectiveness: a national survey during the first week of WHO variant alert publication-title: Front Public Health doi: 10.3389/fpubh.2022.878159 – volume: 38 start-page: 4399 year: 2020 ident: 10.1016/j.vaccine.2022.10.061_b0040 article-title: Routine immunization coverage in Pakistan: a survey of children under 1 year of age in community-based vaccination areas publication-title: Vaccine doi: 10.1016/j.vaccine.2020.04.068 – volume: 372 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0190 article-title: Covid-19 vaccine hesitancy among ethnic minority groups publication-title: BMJ (Clinical Research ed) – ident: 10.1016/j.vaccine.2022.10.061_b0060 – ident: 10.1016/j.vaccine.2022.10.061_b0030 doi: 10.7591/9781501735639 – volume: 15 start-page: 773 year: 2022 ident: 10.1016/j.vaccine.2022.10.061_b0120 article-title: SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes publication-title: J Infect Public Health doi: 10.1016/j.jiph.2022.06.007 – volume: 15 year: 2022 ident: 10.1016/j.vaccine.2022.10.061_b0125 article-title: The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden publication-title: Lancet Reg Health Europe – year: 2022 ident: 10.1016/j.vaccine.2022.10.061_b0155 article-title: Gender, socioeconomic status, and COVID-19 vaccine hesitancy in the US: An intersectionality approach publication-title: Sociol Health Illn doi: 10.1111/1467-9566.13474 – ident: 10.1016/j.vaccine.2022.10.061_b0165 doi: 10.1016/j.vaccine.2014.09.039 – start-page: 5762 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0140 – volume: 63 year: 2022 ident: 10.1016/j.vaccine.2022.10.061_b0180 article-title: Political views and science literacy as indicators of vaccine confidence and COVID-19 concern publication-title: J Prevent Med Hygiene – volume: 589 start-page: 16 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0075 article-title: The lightning-fast quest for COVID vaccines - and what it means for other diseases publication-title: Nature doi: 10.1038/d41586-020-03626-1 – volume: 121 start-page: 99 year: 2019 ident: 10.1016/j.vaccine.2022.10.061_b0050 article-title: Measles outbreaks in Italy: A paradigm of the re-emergence of vaccine-preventable diseases in developed countries publication-title: Prev Med doi: 10.1016/j.ypmed.2019.02.011 – start-page: 1 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0105 article-title: Investigating the determinants of vaccine hesitancy within undergraduate students' social sphere publication-title: J Public Health – volume: 9 start-page: 2649 year: 2013 ident: 10.1016/j.vaccine.2022.10.061_b0175 article-title: Sources of HPV vaccine hesitancy in parents publication-title: Human Vaccines Immunother doi: 10.4161/hv.26224 – ident: 10.1016/j.vaccine.2022.10.061_b0070 – volume: 397 start-page: 1023 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0095 article-title: Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment publication-title: Lancet doi: 10.1016/S0140-6736(21)00306-8 – ident: 10.1016/j.vaccine.2022.10.061_b0150 doi: 10.15585/mmwr.mm7105a3 – volume: 324 start-page: 931 year: 2020 ident: 10.1016/j.vaccine.2022.10.061_b0090 article-title: Unwavering Regulatory Safeguards for COVID-19 Vaccines publication-title: JAMA doi: 10.1001/jama.2020.15725 – volume: 10 year: 2022 ident: 10.1016/j.vaccine.2022.10.061_b0160 article-title: Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust publication-title: Front Public Health doi: 10.3389/fpubh.2022.824560 – volume: 23 year: 2020 ident: 10.1016/j.vaccine.2022.10.061_b0170 article-title: Attitudes toward vaccinations are becoming more polarized in New Zealand: Findings from a longitudinal survey publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2020.100387 – volume: 398 start-page: 2084 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0020 article-title: The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study publication-title: Lancet doi: 10.1016/S0140-6736(21)02178-4 – ident: 10.1016/j.vaccine.2022.10.061_b0145 doi: 10.3389/fpubh.2021.752323 – volume: 24 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0130 article-title: Factors associated with COVID-19 vaccine trust and hesitancy among adults with chronic conditions publication-title: Prevent Med Rep – ident: 10.1016/j.vaccine.2022.10.061_b0005 – start-page: 1 year: 2022 ident: 10.1016/j.vaccine.2022.10.061_b0135 article-title: Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis publication-title: Zeitschrift fur Gesundheitswissenschaften = J Public Health – volume: 16 start-page: e0258462 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0065 article-title: Individual determinants of COVID-19 vaccine hesitancy publication-title: PLoS ONE doi: 10.1371/journal.pone.0258462 – volume: 191 start-page: 71 year: 2022 ident: 10.1016/j.vaccine.2022.10.061_b0085 article-title: Psychological factors affecting COVID-19 vaccine hesitancy publication-title: Ir J Med Sci doi: 10.1007/s11845-021-02640-0 – ident: 10.1016/j.vaccine.2022.10.061_b0045 – volume: 194 start-page: 245 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0080 article-title: Vaccine hesitancy in the era of COVID-19 publication-title: Public Health doi: 10.1016/j.puhe.2021.02.025 – ident: 10.1016/j.vaccine.2022.10.061_b0010 doi: 10.1016/B978-1-4160-3611-1.50005-2 – ident: 10.1016/j.vaccine.2022.10.061_b0035 – volume: 9 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0185 article-title: Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study publication-title: Lancet Reg Health Europe – volume: 16 year: 2021 ident: 10.1016/j.vaccine.2022.10.061_b0110 article-title: COVID-19 and vaccine hesitancy: A longitudinal study publication-title: PLoS ONE doi: 10.1371/journal.pone.0250123 – ident: 10.1016/j.vaccine.2022.10.061_b0015 doi: 10.1016/j.immuni.2021.07.017 – ident: 10.1016/j.vaccine.2022.10.061_b0100 doi: 10.1016/j.vaccine.2017.12.043 |
SSID | ssj0005319 |
Score | 2.5339549 |
Snippet | •Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence.•Vaccine confidence has significantly declined since the onset of... Highlights•Two cohorts were surveyed in 2019 and 2022 respectively to evaluate their vaccine confidence. •Vaccine confidence has significantly declined since... Vaccines are among the safest and most effective primary prevention measures. Thanks to the synergistic global efforts of research institutions, pharmaceutical... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 7262 |
SubjectTerms | Allergy and Immunology Confidence Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 infection COVID-19 vaccines COVID-19 Vaccines - therapeutic use Demographics Demography Ethics gender Health services Humans Immunization Programs Measles Middle Aged nationalities and ethnic groups pandemic Pandemics Pandemics - prevention & control Pharmaceutical industry Polls & surveys Public health Research facilities Research institutions Social networks Statistical analysis Success Survey Surveys Trends vaccination Vaccine confidence Vaccine hesitancy Vaccines |
SummonAdditionalLinks | – databaseName: Science Direct dbid: .~1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBelsLGXsWVfWbuhwehTnTj6tJ_GSFfaQbfC2pI3YckSTVmdMCeFvvRv30mWnWZd6dhj7LvYkk53v7PuA6GPklKqqSgTzqRMGGEuyR3liclY7krrClv675BH38TBKfs64ZMNNG5zYXxYZdT9jU4P2jpeGcbZHM6n0-GPNNjydELAhlEqfcIvY9JL-eDmVpgHDc09PHHiqVdZPMOLwVVh_PE1uImEDHyQlxjdZ5_u4s8_wyhv2aX9Z-hpBJT4c_POz9GGrXroUdNi8rqHHh_Fw_Me2jluylRf7-KTVdZVvYt38PGqgDXw9M58jExI1MUt-wu0d1jjOBIMTrRrupHiosLLyvcJMIBd8ZXPMLnEM4cBWOLx97PDvWSU47n_VH05NZ9eotP9LyfjgyT2YEgMF3KRANzROnMAK7kptSuFZIblrCxsXkgqtHGSG8OL1IWl1Rk1YBJTzbJyJCyz9BXarGaVfYMw0YYS54wk5YgVjmRc58RoAz44c8KUfcTamVcmFij3fTJ-qjYS7ULFYSq_YP4yLFgfDTq2eVOh4yEG0S6ratNPQWEqsCEPMcq_Mdo6bvtajVRNVKruiGYfZR3nmnT_y0O3W8lT3XMAc0rwq1MO__yhuw2KwZ_2FJWdLQNNKHSQivtpPJpOGXjEQPO6EeZuDqmAbQzgHEa9JuYdgS9Mvn6nmp6HAuWhixDjb_9_1Fvoif_lkz5Jto02F7-W9h2gv4V-H7b3b2O8WP0 priority: 102 providerName: Elsevier |
Title | Is vaccine confidence an unexpected victim of the COVID-19 pandemic? |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X22013378 https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X22013378 https://dx.doi.org/10.1016/j.vaccine.2022.10.061 https://www.ncbi.nlm.nih.gov/pubmed/36333226 https://www.proquest.com/docview/2737448058 https://www.proquest.com/docview/2732543106 https://www.proquest.com/docview/3242041486 https://pubmed.ncbi.nlm.nih.gov/PMC9618445 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJhASQhA-VhiTkdCeli6xHTt5mka3qQWtVLBNfbNiJxabtrSQdtJe-Ns5J07CgDFe2qrxJXXPvvvd-T4QeicopYryzI-YED4jzPiJoZGvY5aYLDdpnlk_5NGYD0_Yh2k0dQ630oVVNjKxEtTZTFsf-Q6oWQGmRBDFu_Nvvu0aZU9XXQuNFbRmS5fZkC4xFV2IB60ae4CZwXwWBtMug2fnvH-Vant0DSYiIX0b4MXD23TTn9jz9xDKX3TS4RP02IFJvFdz_ym6lxceul-3l7z20IMjd3Duoa1JXaL6ehsfdxlX5TbewpOueDXQPKr9eLhOT_KQd2rjZaqkXdzc7hnaH5XYzQyDQW3qzqQ4LfCysD0DNOBYfGWzTS7xzGAAmXjw6XS074cJnlu39eWZ3n2OTg4PjgdD3_Vj8HXExcIH6KNUbABiRjpTJuOCaZawLM2TVFCutBGR1lEamIrNKqYa1GOgWJyFPGc5fYFWi1mRryNMlKbEGC1IFrLUkDhSCdFKgz3ODNdZD7GGE1K7YuW2Z8aFbKLSzqWbprQMtF8DA3uo35LN62oddxHwhs2ySUUF4SlBn9xFKP5GmJdOBJQylCWRgfwSVJAzmBKAWpSKuIfiltKhnBq9_M9DN5qVKNvndBujh962l0FI2JOftMhny2pMVfQg4LePscg6YGAdw5iX9eJu_0PKYUsDUIdZ31j27QBbpPzmleLsa1WsvOooxKJX__7pr9FDO0-b5EniDbS6-L7M3wDaW6hNtNL_EW5WGxte4wF8XtsbfRyO4f39wXjy-Sc_EljS |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTnxICEH5KgwwEuxp6RLbSZwHNMG6qWVrqVg39c0kTiw2sbSQdqj_FH8j53yVAWO87DX2JXHucvc7-z4AXvmMsYh5seVy37c45doKNHMtJXig40SHSWz2IfsDr3vI34_d8Qr8qHJhTFhlpRNzRR1PlNkj30Qz66MrYbtia_rVMl2jzOlq1UKjEIu9ZPEdXbbsTa-D_H1N6e7OaLtrlV0FLOV6_sxCAx5FQiNQclUc6djzueIBj8MkCH3mRUr7rlJuaOv8ZSPBFCp5O-IidryEJwzvew1WOUNXpgGr73YGw4_LoBKWtxJBx4Zb3LHHy5yhzZP2WajMYTk6pZS2TUiZ51xkDf9Eu78Hbf5iBXfvwp0SvpK3hbzdg5UkbcL1oqHlogk3-uVRfRPWh0VR7MUGGS1zvLINsk6Gy3LZSHO72DkkRUJUE5pHJkInTxMm1e3uQ6eXkXJlBF14XfRCJWFK5qnpUqAQOZMzk99ySiaaIKwl2x-Oeh3LCcjUbJSfHqutB3B4Jbx6CI10kiaPgdBIMaq18mns8FBT4UYBVZESQnDtqbgFvOKEVGV5dNOl44us4uBOZLlMaRhoLiMDW9CuyaZFfZDLCLyKzbJKfkV1LdGCXUbo_40wyUqlk0lHZlTa8sDOQa49pgjuGPNFC0RNWeKqAi_9z0PXKkmU9XOWv2ILXtbDqJbMWVOYJpN5Picvs2B7F88xWN7m6I_jnEeFcNffkHmoRNA1wFWfE_t6gimLfn4kPf6cl0fPexhx98m_X_0F3OyO-vtyvzfYewq3zJpNiikVa9CYfZsnzxBrzqLn5Q9O4NNV65SfICCURA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGEBMSQlC-CgOMBHta2sR2bOcBTWilWhkbldimvJnEscUmlhbSDvVf46_jnK8yYIyXvSa-JM6d735n3wdCLwWlNKU880ImhMcIs15kaehpySKbGZuYzO1D7u3znUP2Lg7jFfSjyYVxYZWNTiwVdTbRbo-8D2ZWgCvhh7Jv67CI8WC4Nf3quQ5S7qS1aadRiciuWXwH9614PRoAr18RMnx7sL3j1R0GPB1yMfPAmKeptACaQp2lNuOCaRaxLDFRIihPtRWh1mHi2_LDU0k1KHw_ZTILuGGGwnOvoeuChoFbYyIWy_ASWjYVAReHeSzw42X2UP-kd5Zod2wO7ikhPRdcxoOL7OKfuPf38M1f7OHwDrpdA1n8ppK8u2jF5B10o2ptueigtb360L6DNsZVeezFJj5YZnsVm3gDj5eFs4HmVrWHiKvUqA7qHLlYnTJhGDePu4cGowLXM8PgzNuqKypOcjzPXb8CDRgan7lMl1M8sRgALt7-cDQaeEGEp27L_PRYb91Hh1fCqQdoNZ_k5hHCJNWUWKsFyQKWWCLDNCI61VJKZrnOuog1nFC6LpTu-nV8UU1E3Imqp6kcA91lYGAX9VqyaVUp5DIC3rBZNWmwoLgV2LLLCMXfCE1Rq59CBaogylcf_RLu-jEBmEepkF0kW8oaYVXI6X9eut5Iomrfs1yUXfSivQ0Kyp06JbmZzMsxZcEFn188xqF6n4FnDmMeVsLd_kPKQZ2AkwCzPif27QBXIP38nfz4c1kovexmxMLH__7052gNNIl6P9rffYJuuim7XFMi19Hq7NvcPAXQOUuflasbo09XrU5-AjXOlxQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+vaccine+confidence+an+unexpected+victim+of+the+COVID-19+pandemic%3F&rft.jtitle=Vaccine&rft.au=Siani%2C+Alessandro&rft.au=Tranter%2C+Amy&rft.date=2022-11-28&rft.pub=Elsevier+Limited&rft.issn=0264-410X&rft.eissn=1873-2518&rft.volume=40&rft.issue=50&rft.spage=7262&rft_id=info:doi/10.1016%2Fj.vaccine.2022.10.061&rft.externalDBID=HAS_PDF_LINK |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X22X00492%2Fcov150h.gif |